Activist investor Politan files lawsuit against Masimo-July 2024-www.financetom.com

Activist investor Politan files lawsuit against Masimo

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Activist investor Politan files lawsuit against Masimo

Jul 17, 2024 2:55 PM

July 17 (Reuters) - Activist investor Politan has filed

a lawsuit against medical device maker Masimo Corp ( MASI ),

seeking to have the company hold its annual meeting as soon as

possible.

The development comes a day after Masimo ( MASI ) filed a lawsuit

against Politan Capital, seeking to force the activist investor

to correct "material misstatements and omissions" in its proxy

materials.

Previous page： Dyne Therapeutics Names Erick Lucera as CFO Next page： Lennar Shares Slide After 'Weakness In The Market' Leads To Lower Sales Prices And Gross Margin

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Dyne Therapeutics Names Erick Lucera as CFO

Mar 20, 2025

05:35 PM EDT, 03/20/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) appointed Erick Lucera as chief financial officer, effective March 31. Lucera, 57, was previously CFO at Editas Medicine ( EDIT ) , Dyne Therapeutics ( DYN ) said Thursday in a regulatory filing. Separately, Editas named Amy Parison as CFO, effective March 28. Parison, 39, most recently was...

Lennar Shares Slide After 'Weakness In The Market' Leads To Lower Sales Prices And Gross Margin

Mar 20, 2025

Lennar Corp. ( LEN ) released its first-quarter results after Thursday's closing bell. Here's a look at the details from the report. The Details: Lennar ( LEN ) reported quarterly earnings of $2.14 per share. which beat the analyst consensus estimate of $1.73. Quarterly GAAP revenue came in at $7.63 billion, beating the consensus estimate of $7.43 billion. Read Next: Darden...

K-Bro Linen Reports Mixed Earnings In Q4 Despite Higher Revenues

Mar 20, 2025

05:40 PM EDT, 03/20/2025 (MT Newswires) -- K-Bro Linen Inc. ( KBRLF ) after trade Thursday reported mixed earnings for the fourth quarter, even as it had higher revenues buoyed by recent acquisitions, and said it was excited about its organic growth prospects and potential future M&A. For Q4, K-Bro reported adjusted basic earnings per share of $0.344 versus $0.466...

Rhythm Pharmaceuticals Regains Licensing Rights to Imcivree Obesity Drug

Mar 20, 2025

05:29 PM EDT, 03/20/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) said late Thursday it has reacquired rights to its Imcivree obesity medication throughout mainland China, Hong Kong and Macau after terminating its 2021 licensing deal with RareStone Group. As part of the agreement to regain the global franchise for Imcivree, Rhythm said it will repay $6.3 million in...